Search

everythinglearnresearchcommunity

for

Search:↓

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Low-Level Light Therapy (LLLT) is a safe and effective method for skin rejuvenation, acne treatment, wound healing, body contouring, and hair growth, but more well-designed trials are needed for confirmation.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Policemen have more hair loss due to obesity, sunlight exposure, and stress.

Model improves accuracy in predicting hair loss effects.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Married Egyptian women with PCOS have lower sexual desire compared to those without PCOS.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Testosterone improves mood and thinking skills; finasteride has no effect.

Media images promote unrealistic beauty standards, affecting body image and eating disorders globally.

Dermatological conditions are complex, and treatments have mixed results.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Genetic factors can help predict male pattern baldness risk.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.